Dr. Sol Del Mar Aldrete Audiffred, MD

Dr. Aldrete Audiffred practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Aldrete Audiffred's NPI, 1396059838, was assigned on July 26, 2010. Dr. Aldrete Audiffred holds Wisconsin license 65818.

Dr. Aldrete Audiffred's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Aldrete Audiffred's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Aldrete Audiffred to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aldrete Audiffred practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Aldrete Audiffred's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Aldrete Audiffred is licensed in Wisconsin.

CMS data shows 95 Medicare services from Dr. Aldrete Audiffred across 4 procedure codes in 2024, for 65 Medicare patients. Medicare paid $7,616 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Aldrete Audiffred in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aldrete Audiffred's median patient age at 53, with 42% women.

In 2024, Dr. Aldrete Audiffred wrote 1,626 Medicare Part D claims for 101 patients. 55% of them were for generic drugs. CMS names the drug for 1,296 of them, across 49 drugs with 11 or more claims each, at $1,907,369 in total drug cost. In 2023, CMS named 1,307 claims across 50 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Aldrete Audiffred for performance year 2024, reported as part of a group. Dr. Aldrete Audiffred accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Aldrete Audiffred from 2 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 71% of the total. Gilead Sciences, Inc. paid the most, $243. It also lists 4 research payments totaling $1,277 in 2023.